Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Portfolio Pulse from Lisa Levin
Several stocks experienced significant movement in Monday's mid-day session. TransCode Therapeutics, FaZe Holdings, Avalo Therapeutics, Biophytis, Cano Health, Sharps Technology, CalciMedica, TradeUP Acquisition Corp., So-Young International, Shattuck Labs, Pasithea Therapeutics, Enthusiast Gaming Holdings, InnSuites Hospitality Trust, Canopy Growth Corporation, ESS Tech, Solo Brands, Sea Limited, MDB Capital Holdings, Williams-Sonoma, Bridger Aerospace Group Holdings, MIRA Pharmaceuticals, and Energy Fuels Inc. were among the gainers. SCYNEXIS, MicroAlgo, Turbo Energy, Brainstorm Cell Therapeutics, Calidi Biotherapeutics, Rite Aid Corporation, Safe & Green Holdings Corp., Blue Star Foods Corp., GSE Systems, Morphic Holding, Solowin Holdings, Pineapple Energy, Faraday Future Intelligent Electric, AgriFORCE Growing Systems, Alector, Connexa Sports Technologies, CF Acquisition Corp. VIII, Li Auto, Tarena International, VinFast Auto, LivePerson, Editas Medicine, Coherus BioSciences, Hawaiian Holdings, and Alcoa Corporation were among the losers.
September 25, 2023 | 5:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Brainstorm Cell Therapeutics fell 32.6% after the FDA said it does not believe there is sufficient evidence to support that any of the assessed biomarkers for the company's ALS therapy is reasonably likely to predict clinical benefit.
The FDA's doubts about the company's ALS therapy led to a significant decrease in its stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics shares jumped 308% after announcing pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
The company's announcement of positive pre-clinical results led to a significant increase in its stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100